RxDoctor Payments Data

Cathy Criss, DO

Family Medicine · Port Charlotte, FLNPI 1346223229

Payments from drug & device makers

$9,213in general payments, 2019–2025

Across 466 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • Pfizer$778
  • Esperion Therapeutics, Inc.$770
  • Amgen$679
  • GSK$620
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$8,63394%
  • Education$5816%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,213 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$906,630
Medicare patients
1,332
Services billed
29,094

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide208$304,943
EliquisApixaban140$191,561
JardianceEmpagliflozin86$131,285
NexlizetBempedoic Acid/Ezetimibe112$98,274
TrulicityDulaglutide56$78,956
MounjaroTirzepatide58$77,924
ProliaDenosumab44$75,908
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$68,276
Repatha SureclickEvolocumab50$66,104
XareltoRivaroxaban51$64,633
MyrbetriqMirabegron58$61,467
FarxigaDapagliflozin Propanediol43$60,456
Nurtec OdtRimegepant Sulfate35$51,634
LinzessLinaclotide54$51,558
JanuviaSitagliptin Phosphate36$44,657

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$431$304,943208 claims
PfizerEliquis, Nurtec Odt$778$243,195175 claims
Lilly USA, LLCTrulicity, Mounjaro$568$156,880114 claims
Esperion Therapeutics, Inc.Nexlizet, Nexletol$770$134,125155 claims
Boehringer IngelheimJardiance$158$131,28586 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$138$97,64499 claims
Astellas Pharma US IncMyrbetriq, Veozah$597$76,11272 claims
AmgenProlia$679$75,90844 claims
GSKTrelegy Ellipta$620$68,27661 claims
Johnson & JohnsonXarelto$1,441$64,63351 claims
AbbVieLinzess, Synthroid$1,005$57,012173 claims
MerckJanuvia$51$44,65736 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Port Charlotte

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →